The efficacy and safety of basimglurant as adjunctive therapy in major depression; a randomised, double-blind, placebo-controlled study

被引：13
|
作者：
Quiroz, J. A. [1 ]
Tamburri, P. [1 ]
Deptula, D. [1 ]
Banken, L. [2 ]
Beyer, U. [2 ]
Fontoura, P. [3 ]
Santarelli, L. [4 ]
机构：
[1] Roche TCRC Inc, Neurosci Translat Med, New York, NY USA
[2] Roche, Biostat, Basel, Switzerland
[3] Roche, Head Neurosci Translat Med, Basel, Switzerland
[4] Roche, Head Neurosci, Basel, Switzerland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70748-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.f.027
引用
收藏
页码：S468 / S468
页数：1
相关论文
共 50 条
  • [1] The Efficacy and Safety of Basimglurant as Adjunctive Therapy in Major Depression; a Randomized, Double-blind, Placebo Controlled Study
    Quiroz, Jorge
    Tamburri, Paul
    Deptula, Dennis
    Banken, Ludger
    Beyer, Ulrich
    Fontoura, Paulo
    Santarelli, Luca
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S376 - S377
  • [2] Efficacy and Safety of Cariprazine as Adjunctive Therapy in Major Depressive Disorder: A Double-blind, Placebo-controlled Study
    Fava, Maurizio
    Durgam, Suresh
    Mergel, Victor
    Earley, Willie
    Nemeth, Gyoergy
    Laszlovszky, Istvan
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S352 - S353
  • [3] Efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study
    Ebrecht, M.
    Sickmann, V
    Kungel, M.
    Werner, C.
    Marcus, R.
    McQuade, R.
    Modell, S.
    [J]. PHARMACOPSYCHIATRY, 2007, 40 (05) : 207 - 207
  • [4] The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study
    Berman, Robert M.
    Marcus, Ronald N.
    Swanink, Rene
    McQuade, Robert D.
    Carson, William H.
    Corey-Lisle, Patricia K.
    Khan, Arif
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (06) : 843 - 853
  • [5] The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder - A second multicenter, randomized, double-blind, placebo-controlled study
    Marcus, Ronald N.
    McQuade, Robert D.
    Carson, William H.
    Hennicken, Delphine
    Fava, Maurizio
    Simon, Jeffrey S.
    Trivedi, Madhukar H.
    Thase, Michael E.
    Berman, Robert M.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (02) : 156 - 165
  • [6] Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial
    Hoobehfekr, Saba
    Moghaddam, Hossein Sanjari
    Shalbafan, Mohammadreza
    Hashemi, Maryam Ghazizadeh
    Pirmoradi, Mohammad Mehdi
    Sakenian, Amirhossein
    Poopak, Amirhossein
    Kashefinejad, Shayan
    Yarahmadi, Masoomeh
    Akhondzadeh, Shahin
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 75 (02) : 57 - 62
  • [7] Memantine in major depression: A double-blind, placebo-controlled study
    Zarate, CA
    Singh, JB
    Quiroz, JA
    Denicoff, KK
    De Jesus, G
    Luckenbaugh, D
    Manji, HK
    Charney, DS
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S218 - S218
  • [8] Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study
    Lopresti, Adrian L.
    Drummond, Peter D.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2017, 207 : 188 - 196
  • [9] Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trial
    Yatham, Lakshmi N.
    Vieta, Eduard
    Goodwin, Guy M.
    Bourin, Michel
    de Bodinat, Christian
    Laredo, Judith
    Calabrese, Joseph
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2016, 208 (01) : 78 - 86
  • [10] DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF CILOBAMINE IN MAJOR DEPRESSION - LACK OF THERAPEUTIC EFFICACY
    AMSTERDAM, JD
    KAPLAN, M
    POTTER, L
    RICKELS, K
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1986, 39 (01): : 87 - 92
12345